Published in Br J Pharmacol on August 01, 1998
Novel approaches to corticosteroid treatment in Duchenne muscular dystrophy. Phys Med Rehabil Clin N Am (2012) 0.98
Δ-9,11 modification of glucocorticoids dissociates nuclear factor-κB inhibitory efficacy from glucocorticoid response element-associated side effects. J Pharmacol Exp Ther (2012) 0.90
Dexamethasone stimulates store-operated calcium entry and protein degradation in cultured L6 myotubes through a phospholipase A(2)-dependent mechanism. Am J Physiol Cell Physiol (2010) 0.87
Rapid and non-genomic reduction of intracellular [Ca(2+)] induced by aldosterone in human bronchial epithelium. J Physiol (2001) 0.85
Rapid non-genomic inhibition of ATP-induced Cl- secretion by dexamethasone in human bronchial epithelium. J Physiol (2002) 0.83
Small leucine zipper protein (sLZIP) negatively regulates skeletal muscle differentiation via interaction with α-actinin-4. J Biol Chem (2013) 0.82
Prior sprint cycling did not enhance training adaptation, but resting salivary hormones were related to workout power and strength. Eur J Appl Physiol (2009) 0.78
Inhibition of iPLA2 β and of stretch-activated channels by doxorubicin alters dystrophic muscle function. Br J Pharmacol (2013) 0.76
Dexamethasone attenuates the depressor response induced by neuropeptide Y microinjected into the nucleus tractus solitarius in rats. Br J Pharmacol (2000) 0.76
Corticosteroid Treatment Impact on Spinal Deformity in Duchenne Muscular Dystrophy. Int Sch Res Notices (2014) 0.75
Pregnancy-induced amelioration of muscular dystrophy phenotype in mdx mice via muscle membrane stabilization effect of glucocorticoid. PLoS One (2015) 0.75
Dystrophic Cardiomyopathy-Potential Role of Calcium in Pathogenesis, Treatment and Novel Therapies. Genes (Basel) (2017) 0.75
Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases. Trends Pharmacol Sci (1989) 4.41
Reductive cleavage of cystine disulfides with tributylphosphine. Methods Enzymol (1977) 1.68
A human cellular model for studying the regulation of glucagon-like peptide-1 secretion. Endocrinology (2001) 1.56
Stereoselectivity at the calcium channel: opposite action of the enantiomers of a 1,4-dihydropyridine. J Cardiovasc Pharmacol (1985) 1.49
Human lymphoblastoid interferon. Large scale production and partial purification. J Biol Chem (1977) 1.24
A rapid and sensitive assay for arginase. Anal Biochem (1980) 1.13
Cyclosporine A up-regulates angiotensin II receptors and calcium responses in human vascular smooth muscle cells. Kidney Int (1999) 1.07
Regulation of cytosolic calcium in skeletal muscle cells of the mdx mouse under conditions of stress. Br J Pharmacol (1996) 1.05
Vasopressin induced production of inositol trisphosphate and calcium efflux in a smooth muscle cell line. Biochem Biophys Res Commun (1985) 1.03
Lack of evidence for voltage dependent calcium channels on platelets. Biochem Biophys Res Commun (1985) 0.97
Solubilization of an active opiate receptor from Bufo marinus. Eur J Pharmacol (1980) 0.97
Studies on the mechanism of action of the vasoconstrictive dihydropyridine, CGP 28392. Eur J Pharmacol (1984) 0.93
Growth of dissociated neurons in culture dishes coated with synthetic polymeric amines. Neurosci Lett (1984) 0.93
Effect of cyclosporin A and analogues on cytosolic calcium and vasoconstriction: possible lack of relationship to immunosuppressive activity. Br J Pharmacol (1996) 0.91
Creatine supplementation improves intracellular Ca2+ handling and survival in mdx skeletal muscle cells. FEBS Lett (1998) 0.89
Cyclosporin A augments angiotensin II-stimulated rise in intracellular free calcium in vascular smooth muscle cells. Biochem J (1987) 0.87
Increase of empty pool-activated Ca2+ influx using an intracellular Ca2+ chelating agent. Biochem Biophys Res Commun (1996) 0.87
Modulation by prednisolone of calcium handling in skeletal muscle cells. Br J Pharmacol (1995) 0.87
Differential blockade of agonist- and depolarization-induced 45Ca2+ influx in smooth muscle cells. Am J Physiol (1989) 0.86
Alkylation of cysteine thiols with 1,3-propane sultone. Methods Enzymol (1977) 0.85
Serotonin increases the production of inositol phosphates and mobilises calcium via the 5-HT2 receptor in A7r5 smooth muscle cells. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.85
Cyclosporin A potentiates receptor-activated [Ca2+]c increase. J Recept Signal Transduct Res (1997) 0.83
Reaction of cysteine thiol groups with 1,3-propane sultone: S-3-sulphopropyl as a modifying group for protein chemistry. Int J Pept Protein Res (1974) 0.82
A smooth muscle cell line suitable for the study of voltage sensitive calcium channels. Biochem Biophys Res Commun (1985) 0.81
Mechanism of enhanced vasoconstrictor hormone action in vascular smooth muscle cells by cyclosporin A. Br J Pharmacol (1997) 0.80
Purification and chemical characterization of melittin and acetylated derivatives. Biochim Biophys Acta (1980) 0.80
Vasopressin increases 45Ca2+ influx in rat aortic smooth muscle cells. Biochem Biophys Res Commun (1987) 0.80
Biphasic effects of cyclosporin A on formyl-methionyl-leucyl-phenylalanine stimulated responses in HL-60 cells differentiated into neutrophils. Br J Pharmacol (1998) 0.80
Reduction of S-sulpho groups by tributylphosphine: an improved method for the recombination of insulin chains. Hoppe Seylers Z Physiol Chem (1975) 0.80
4-pyridylmethyl, a thiol-protecting group suitable for the partial synthesis of proteins. Biochem J (1979) 0.79
Correlation between substance P content of primary sensory neurones and pain sensitivity in rats exposed to antibodies to nerve growth factor. Eur J Pharmacol (1982) 0.79
Modulation of electrical activity and of intracellular calcium oscillations of smooth muscle cells by calcium antagonists, agonists, and vasopressin. J Cardiovasc Pharmacol (1991) 0.79
Studies on capacitative calcium entry in vascular smooth muscle cells by measuring 45CA2+ influx. J Recept Signal Transduct Res (1997) 0.78
Metabolism-dependent stimulation of reactive oxygen species and DNA synthesis by cyclosporin A in rat smooth muscle cells. Free Radic Biol Med (1999) 0.77
Reductive cleavage of S-sulfo groups with tributylphosphine. Methods Enzymol (1977) 0.76
Calcium antagonists in experimental atherosclerosis. Use-dependence of isradipine: a potential explanation for enhanced action in atherosclerotic animals and tissue selectivity. Am J Hypertens (1991) 0.76
Platelet-activating factor mobilizes intracellular calcium in vascular smooth muscle cells. FEBS Lett (1986) 0.76
Antivasoconstrictor effects of isradipine. A quantitative approach in anesthetized rats and conscious rabbits. Am J Med (1989) 0.76
2-Sulphobenzyl, a new solubilizing and reversible protecting group for cysteine in proteins. Its scope and limitations. Biochem J (1979) 0.75
Calcium homeostasis and glucose uptake of murine myotubes exposed to insulin, caffeine and 4-chloro-m-cresol. Acta Physiol Scand (2002) 0.75
Pharmacological actions of SDZ 218-135, a novel positive inotropic agent. Cardiovasc Drugs Ther (1994) 0.75
Inactivation and solubilization of opiate receptors by phospholipases A2. Biochim Biophys Acta (1982) 0.75
Vascular selectivity of seven prototype calcium antagonists: a study at the single cell level. J Cardiovasc Pharmacol (1993) 0.75